Dr. Reddy’s Secures License from Henlius to Market Daratumumab Biosimilar in the U.S. and Europe
FDA Approves New Biologic Cancer Treatments
Daewoong and Celltrion to Market Denosumab Biosimilar in Korea
FDA Approves Samsung’s Eculizumab Biosimilar
Alexion’s Preliminary Injunction Motion Denied in Eculizumab BPCIA Litigation Against Samsung Bioepis
FDA Approves New Indication for AstraZeneca and Daiichi Sankyo’s Cancer Drug ENHERTU
FDA Approves Sandoz Denosumab Biosimilars
Biocon Settles with Bayer and Regeneron, Securing Canada Market Entry Date for Aflibercept Biosimilar
Biocon Settles with Janssen, Securing U.S. Market Entry Date for Ustekinumab Biosimilar
Subscribe: Subscribe via RSS
Blogs
Firm/Org